An experienced investor and FinTech expert, member of the Business Council of the Longevity Medicine Association.

As CEO of Corviglia Capital Fund (a London-based growth capital fund focused on FinTech) and former founder and managing partner of Private Equity Managers SA, he invests in new technologies. He co-created Alior Bank (the first Polish FinTech unicorn), where as Vice President he was responsible for IT, operations, and corporate banking. He has over 20 years of experience in banking (including Bank Handlowy, Pekao, Alior Bank) and 5 years in the fuel sector (PKN Orlen, PGNiG). He has sat on the supervisory boards of more than 20 companies across various industries. Graduate of the Warsaw University of Technology, the Faculty of Law at the University of Warsaw, MBA (Chicago Booth), and postgraduate studies in economics and international law (Turin, Lausanne). He has invested in companies such as Twisto, uPaid (Verestro), AnnaMoney, Rebellpay, Sparados, 3Soft SA, and earlier was involved with ATM, eCard, Dotpay, Netia, and Lifebrain.

Dagmara Kryśkiewicz – an expert in regulatory compliance, with a legal background and many years of experience in European financial and investment markets. She moves with equal ease in the world of complex regulations as she does in conversations about the future of longevity.

She co-founded Agenox – an initiative that combines preventive healthcare with the latest scientific achievements. The Agenox team believes that longevity is more than just the number of years — it is the quality of everyday life and a conscious, individualized approach to health. That is why they create personalized strategies addressing specific challenges — from early diagnostics, through proactive health management, to comprehensive anti-aging methods. At the same time, as an Associate at MI – Multiple Impact, a boutique advisory firm specializing in alternative operational assets, she supports the development of innovative housing concepts for people aged 60+. Her goal is to build communities that foster a positive mindset, inspire activity, and give a sense of purpose — supporting long, fulfilling lives. She is a member of the Senior Housing and Healthcare Association (SHHA), engaged in promoting a healthy lifestyle combined with a modern approach to care and living spaces for older adults.

Specialist in Orthopedics and Traumatology of the Musculoskeletal System, Director of Innovation at Alab Laboratories A physician with over 15 years of clinical experience, specializing in orthopedics and traumatology of the musculoskeletal system.

He currently serves as Director of Innovation at Alab Laboratories, where he is responsible for the development and implementation of modern technologies in laboratory diagnostics. His work focuses on digitalization, automation, and data integration to enhance the quality, accessibility, and precision of modern diagnostics. Graduate of the Medical University of Warsaw and participant of the Global Healthcare Leaders Program at Harvard Medical School (2023–2024). He also completed the Healthcare Leadership and Innovation program at INSEAD Executive Education. He is involved in innovations at the intersection of medicine, technology, and laboratory data management. He supports the development of solutions that enable early disease detection, personalized prevention, and monitoring of biological aging processes. His particular area of interest is the role of modern laboratory diagnostics in promoting functional longevity and proactive medicine. Privately, he is passionate about offshore sailing and snowboarding.

A specialist anesthesiologist with over 30 years of clinical experience, focusing on transplant anesthesia and perioperative medicine.

Expert in pharmacogenomics, pharmacokinetics, and neuropharmacology. Author of more than 250 peer-reviewed scientific publications indexed in Medline, over 200 abstracts presented at national and international scientific conferences, and 25 book chapters. His work has been cited more than 2,490 times (H-index: 27). He has held leadership and academic positions at, among others, Penn State College of Medicine (USA), Vanderbilt University Medical Center (USA), University of Cape Town (South Africa), and the Medical University of Warsaw (Poland). Currently affiliated with the Hershey Medical Center and the Veterans Administration Medical Center in Pennsylvania, USA. Certified by the American Board of Anesthesiology and in Clinical Pharmacology.

A hematologist, scientist, innovator, and academic teacher at the Medical University of Warsaw. He holds a habilitation degree in medical sciences and completed his specialization in hematology at the Department of Hematology, Transplantology and Internal Medicine, University Clinical Center of the Medical University of Warsaw. Founder, originator, and President of the Human Biome Institute – a modern research and development company focused on the human microbiome and operating a microbiota bank.

Laureate of numerous awards and distinctions, including the Faculty Award of the 5th Medical Division of the Polish Academy of Sciences, the “Golden OTIS” Award in the category Scientific Debut of the Year, 5th place in the Supertalents in Medicine competition (2025), and a scholarship from the Polish Ministry of Science and Higher Education. In 2020, he became a “Young Ambassador” of the European Society for Blood and Marrow Transplantation (EBMT). Author of numerous scientific publications with a total Impact Factor >200, H-index 15, and over 1,000 citations. Principal investigator in seven scientific grants and lead researcher in international clinical trials. His scientific work covers hematology, transplantology, immunology, the gut microbiome, and healthy aging (longevity). Currently, he is focused on the development of Human Biome S.A., whose mission is to create a biosynthetic human microbiome and innovative therapies based on it.

Dr. n. med., Dr. n. hum. Natalia Szejko is a neurologist with extensive international clinical and scientific experience, which includes a 1.5-year postdoctoral fellowship at the Department of Neurology, Yale University (USA), where she advanced her expertise in precision medicine, brain health, and the use of genomics in neurology.

She also completed a two-year clinical and research fellowship in movement disorders at the University of Calgary (Canada), funded by the American Brain Foundation, the American Academy of Neurology, and the Tourette Association of America. In 2025, she joined the prestigious group of Brain Health Ambassadors of the European Academy of Neurology. She is the author and co-author of over 100 scientific articles in neurology, mainly on movement disorders but also on brain health. She serves on the board of the Fellows Section of the European Charcot Foundation, where a brain health program for patients with multiple sclerosis is currently being developed; she is also E-Learning Liaison in the European Academy of Neurology (Functional Neurological Disorders Panel), Treasurer and Board Member of the European Society for the Study of Tourette Syndrome, as well as Co–Vice Chair of the International Alliance for Cannabinoid Medicines and a member of the Steering Committee of the Tic Disorders Group, Movement Disorders Society. For her scientific achievements, she has received numerous awards and fellowships, many of which enabled additional international clinical and research placements, including: Joint Fellowship of the European Huntington's Disease Network and Movement Disorders Society (Department of Neurology, Ramon y Cajal Hospital, Madrid, Spain), Clinical Fellowship of the European Academy of Neurology (Department of Neurology, University of Innsbruck, Austria), Research Fellowship of the Kościuszko Foundation (Yale University, USA), LEAP Fellowship for Young Leaders of the Movement Disorders Society, Prof. Mary Robertson Award, Polityka’s Science Award, Prof. A. Rojszczak Award of the Foundation for Polish Science, Presidents’ Award of the Polish Neurological Society, Ministry of Health Scholarship for the Best Young Scientists, and 4th place in the Supertalents in Medicine competition.

Professor Michał Wszoła – transplant surgeon, CEO of Polbionica S.A., and visionary scientist. He combines clinical experience with innovative biotechnological solutions, creating groundbreaking therapies that are reshaping modern medicine. His work has gained international recognition and funding.

He is the creator of the Bionic Pancreas-ATMP® – a living, vascularized organ designed to restore natural blood sugar regulation and revolutionize the treatment of diabetes and chronic pancreatitis. This breakthrough solution addresses the shortage of organs for transplantation and the complications associated with immunosuppressive therapy. Under his leadership, the team implements the latest achievements in biotechnology, biomaterials, and regenerative medicine, developing personalized therapies tailored to patients. As Chairman of the Scientific Council of the Foundation for Research and Development of Science and Medical Director at MediSpace Hospital, Professor Wszoła is advancing the vision of the European Center for Medical Biotechnology – an innovative hub connecting the world of science with clinical medicine.

A graduate of the Medical University of Warsaw, specialist in neurology, holder of an MBA in International Healthcare Management, and the prestigious title of Fellow of the Royal Australasian College of Physicians (FRACP). He gained his clinical and managerial experience at leading medical centers worldwide, including HUS Helsinki, CHUV Lausanne, King’s College Hospital London, Cleveland Clinic Abu Dhabi, Canberra Health Services, and the Institute for Healthier Living Abu Dhabi.

His main areas of interest are preventive medicine, causal medicine, and longevity. He leads innovative projects using artificial intelligence, real-world data analysis, and personalized lifestyle interventions. He has been a member of the World Health Organization editorial group responsible for updating the Helsingborg Declaration on the prevention of neurological diseases in 2006, and is now actively co-developing international strategies for longevity and preventive medicine, particularly in vascular and neurological diseases. Author of numerous scientific publications indexed in PubMed, with recognized international impact confirmed by Google Scholar metrics. Within the Polish Society of Longevity Medicine, he brings a global perspective, strategic leadership, and expert knowledge supporting the development of longevity medicine in Poland.

Microbiologist and entrepreneur, specialist in molecular biology and microbiology with a particular focus on the microbiome and its impact on longevity.

Earned her PhD at Humboldt University in Berlin. Fellow of the Top100 Scientists program. She has worked with biotechnology startups in the United States and Germany, and co-founded a company developing science-based consumer solutions. She combines an interdisciplinary approach with a passion for innovation. Co-founder of the Polish Society of Longevity Medicine.

Physiotherapist and Assistant Professor at the 3rd Department of Internal Medicine and Cardiology, Medical University of Warsaw.

Member of the Sports Cardiology Section of the Polish Cardiac Society. Specializes in clinical physiotherapy, sports recovery, and kinesio-gerontoprophylaxis. Physiotherapist of the Polish Olympic Mission, advocate of physical activity as a key element in chronic disease prevention. Frequent media guest and author of numerous publications. Co-founder of the Polish Society of Longevity Medicine.

Cardiologist and Vice-Rector of the Medical University of Białystok for Preventive Medicine and Open Science. Head of the Department of Cardiology and the Department of Population Medicine at UMB.

Initiator of the “Białystok+” population study. Specializes in the prevention of lifestyle diseases, population medicine, and medical innovations. Author of over 200 publications in leading scientific journals. Recipient of numerous awards and fellowships in the USA, Germany, and the UK. Co-founder of the Polish Society of Longevity Medicine.

Cardiologist and professor at the Medical University of Warsaw, head of the Pharmacogenomics Laboratory at the University’s Preclinical Research Center.

An expert in longevity and aging. Fulbright Fellow at Penn State College of Medicine (USA) and graduate in health economics from the London School of Economics. Co-hosts the “Kierunek Długowieczność” program on Polish Radio Channel 3 and the podcast “W stronę długowieczności”. Co-founder and Chair of the Polish Society of Longevity Medicine.